Other
Common Stock, Shares, Outstanding
Neurocrine Biosciences Common Stock, Shares, Outstanding increased by 0.5% to $100.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.6%, from $99.00M to $100.60M. Over 5 years (FY 2020 to FY 2025), Common Stock, Shares, Outstanding shows relatively stable performance with a 1.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ1 2026May 5, 2026
How to read this metric
A decrease indicates share buybacks, which can boost EPS, while an increase suggests equity issuance, which may dilute existing shareholders.
Detailed definition
This is the total number of common shares held by all shareholders, excluding treasury shares. It is the primary denomin...
Peer comparison
Standardized metric used globally to assess equity dilution and ownership structure.
Metric ID:
other_common_stock_shares_outstandingHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $94.60M | $94.80M | $94.90M | $95.50M | $95.60M | $96.10M | $96.50M | $97.50M | $97.60M | $98.20M | $98.70M | $100.60M | $100.90M | $101.20M | $99.40M | $99.00M | $99.00M | $99.70M | $100.10M | $100.60M |
| QoQ Change | — | +0.2% | +0.1% | +0.6% | +0.1% | +0.5% | +0.4% | +1.0% | +0.1% | +0.6% | +0.5% | +1.9% | +0.3% | +0.3% | -1.8% | -0.4% | +0.0% | +0.7% | +0.4% | +0.5% |
| YoY Change | — | — | — | — | +1.1% | +1.4% | +1.7% | +2.1% | +2.1% | +2.2% | +2.3% | +3.2% | +3.4% | +3.1% | +0.7% | -1.6% | -1.9% | -1.5% | +0.7% | +1.6% |
Range$94.60M – $101.20M
CAGR+1.3%
Avg YoY Growth+1.3%
Median YoY Growth+1.7%
Current Streak4 quarters growth
Common Stock, Shares, Outstanding at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's common stock, shares, outstanding?
- Neurocrine Biosciences (NBIX) reported common stock, shares, outstanding of $100.60M in Q1 2026.
- How has Neurocrine Biosciences's common stock, shares, outstanding changed year-over-year?
- Neurocrine Biosciences's common stock, shares, outstanding increased by 1.6% year-over-year, from $99.00M to $100.60M.
- What is the long-term trend for Neurocrine Biosciences's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's common stock, shares, outstanding has grown at a 1.4% compound annual growth rate (CAGR), from $93.50M to $100.10M.
- What does common stock, shares, outstanding mean?
- The total number of shares of common stock currently held by all shareholders.